Billy Evans, a partner of the founder of Theranos, Elizabeth Holmes, is working on a new startup that seeks to deliver “human health optimization” through blood tests, according to the New York Times.
According to reports, the Times spoke with two investors launched in the startup, called Haemanthus, and also saw some of Haemathus’s marketing materials.
In these materials, the company says that it has developed a machine that uses lasers to analyze samples of blood, saliva and urine to detect cancer and infections. According to reports, he plans to start with the health of pets before expanding to humans, and seeks to raise more than $ 50 million.
The tone resonates in Theranos, which promised to perform a variety of medical tests in small amounts of blood extracted from the punctured fingers. In 2022, Holmes (with whom Evans has two children) was a sentence to 11 years in prison for defrauding investors, although he said in a recent interview that he is still “committed to my dream of making avarthare. Healthcare.” “” “
Facebook’s first investor Jim Breyer told the Times that he asked his team to invest, but declined “for many of the same reasons why we passed twice in Theranians.”